an inflammatory disease of connective tissue with variable features including fever and weakness and fatigability and joint pains and skin lesions on the face or neck or arms

objective to discuss the feasibility and effect of labeled antibody on targeting therapy of systemic lupus erythematosus (sle) associated thrombocytopenia.

目的：探讨药物标记抗体导向治疗系统性红斑狼疮（sle）所致血小板减少的可行性及效果。

four patients with systemic lupus erythematosus (sle) who showed either minimal response or no further improvement to corticosteroids and immunosuppressive drugs, were treated with plasmapheresis.

四个全身性红斑狼疮（sle）病人，因对皮质类固醇及免疫抑制剂治疗的效果不明显或不再进步而采用血浆换出治疗。

systemic lupus erythematosus ( sle ) is a multifactorial disease and its pathogenesis and precise mechanism remain unknown.

系统性红斑狼疮（sle ）是一种多因素疾病，其病因和发病机制尚未明确。

detect the levels of dendritic cell subsets in systemic lupus erythematosus (sle) patients, and study its correlation with sle activity criteria.

目的检测系统性红斑狼疮患者树突状细胞亚型水平，探讨与疾病活动指数的相关性。

objective to know the occurrence of activated protein c resistance (apcr) in chinese patients with systemic lupus erythematosus (sle) and investigate the occurring mechanism of thrombosis in sle.

目的了解抗活化的蛋白c（apcr）在系统性红斑狼疮（sle）患者中的发生情况，并进一步探讨sle患者发生血栓的机制。

objective to estimate the risk factors in patients with systemic lupus erythematosus (sle) developing central nervous system (cns) disease.

目的探讨系统性红斑狼疮（sle）并发中枢神经系统（cns）病变的危险因素。

objective to delineate the immune regulatory pathway in pathogenesis of systemic lupus erythematosus (sle) by using gene expression profile analysis.

目的通过基因表达谱勾画系统性红斑狼疮（sle）发病机制中可能的免疫调控通路。

objective to research the influence of b lymphocytes, t lymphocytes on systemic lupus erythematosus (sle) patient′s and control′s granulocyte macrophage colony forming unit (gm cfu).

目的探讨系统性红斑狼疮（sle）患者b、t淋巴细胞对sle及正常人骨髓粒巨噬细胞集落形成单位（gmcfu）的影响。

objective to evaluate bone mineral density (bmd) in young ambulatory female patients with systemic lupus erythematosus (sle) and to assess the influence of corticosteroids on bmd.

目的了解系统性红斑狼疮（sle）患者骨矿物质密度（bmd）的变化，并讨论疾病的病情和激素对骨密度的影响。